Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T23:26:05.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-13T05:21:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed, updating the version history to reflect the latest record state.
    Difference
    0.1%
    Check dated 2026-09-21T23:27:58.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    New revision entry (v3.6.6) added to the study history, updating the log to reflect a recent site update.
    Difference
    0.1%
    Check dated 2026-08-31T18:35:48.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The history now shows a newer release revision (v3.6.5) replacing the previous revision (v3.6.4). This reflects a standard site/software update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-10T12:59:04.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The study record history now lists a new revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor system update to the ClinicalTrials.gov record page.
    Difference
    0.1%
    Check dated 2026-07-27T06:39:04.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.